We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFA
951
First Trust Enhanced Equity Income Fund
FFA
$472M
$6.68M 0.01%
516,842
-10,716
-2% -$156K
HEI icon
952
HEICO Corp
HEI
$50.9B
$6.67M 0.01%
86,128
+6,369
+8% +$531K
VCR icon
953
Vanguard Consumer Discretionary ETF
VCR
$6.16B
$6.65M 0.01%
44,209
+18,379
+71% +$2.98M
WCG
954
DELISTED
Wellcare Health Plans, Inc.
WCG
$6.64M 0.01%
28,115
+7,915
+39% +$2.12M
WTFC icon
955
Wintrust Financial
WTFC
$10.7B
$6.63M 0.01%
99,772
-10,275
-9% -$781K
PAA icon
956
Plains All American Pipeline
PAA
$16.4B
$6.63M 0.01%
330,645
-9,414
-3% -$215K
DAR icon
957
Darling Ingredients
DAR
$9.99B
$6.62M 0.01%
343,843
-34,875
-9% -$707K
CINF icon
958
Cincinnati Financial
CINF
$26.7B
$6.59M 0.01%
85,083
+9,103
+12% +$708K
SSNC icon
959
SS&C Technologies
SSNC
$18.7B
$6.58M 0.01%
145,874
-202,437
-58% -$9.83M
DEM icon
960
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$6.57M 0.01%
163,661
-18,305
-10% -$750K
PPLI
961
People Inc
PPLI
$3.03B
$6.55M 0.01%
200,276
-62,635
-24% -$2.1M
COR
962
DELISTED
Coresite Realty Corporation
COR
$6.55M 0.01%
75,111
-3,651
-5% -$354K
HXL icon
963
Hexcel
HXL
$7.63B
$6.55M 0.01%
114,252
-19,433
-15% -$1.17M
BBWI icon
964
Bath & Body Works
BBWI
$3.89B
$6.55M 0.01%
315,561
-36,497
-10% -$920K
ACGL icon
965
Arch Capital
ACGL
$33.5B
$6.53M 0.01%
244,289
-10,619
-4% -$294K
CLB icon
966
Core Laboratories
CLB
$561M
$6.48M 0.01%
108,723
-57,994
-35% -$5M
DVN icon
967
Devon Energy
DVN
$49.9B
$6.47M 0.01%
287,181
-115,068
-29% -$3.54M
JWN
968
DELISTED
Nordstrom
JWN
$6.47M 0.01%
138,880
+47,736
+52% +$2.69M
FNF icon
969
Fidelity National Financial
FNF
$12.9B
$6.47M 0.01%
213,873
+16,550
+8% +$534K
WKC icon
970
World Kinect Corp
WKC
$1.89B
$6.46M 0.01%
301,892
+2,862
+1% +$75.4K
ETSY icon
971
Etsy
ETSY
$7.38B
$6.44M 0.01%
135,466
+74,396
+122% +$3.5M
RSPH icon
972
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$794M
$6.43M 0.01%
361,980
-5,750
-2% -$109K
KWR icon
973
Quaker Houghton
KWR
$2.96B
$6.42M 0.01%
36,114
+15,683
+77% +$3.02M
HF
974
DELISTED
HFF Inc.
HF
$6.42M 0.01%
193,549
-8,196
-4% -$305K
NUO
975
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
$6.41M 0.01%
481,995
+105,913
+28% +$1.41M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.